Navigation Links
IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
Date:6/7/2012

NEW YORK, June 7, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTCQB: SVFC) announced today that Dr. Arnold I. Caplan has joined its Scientific Advisory Board.  Dr. Steven Victor, CEO of IntelliCell, stated "Dr. Caplan's expertise in regenerative medicine is acknowledged in our entire industry and we are very pleased to have him assist our company as it moves forward.  Dr. Caplan's unique experience in our industry has helped emerging companies take many products from the laboratory and into successful commercialization and our team is looking forward to learning and working with him."  Professor Caplan has lectured and published extensively in the field of regenerative medicine including stem cells, development and bone biology and is recognized as one of the world's foremost authorities on cellular therapies.  Dr. Caplan stated, "The IntelliCell product is a platform for cellular delivery to promote and support the natural regeneration of focal injuries that may occur almost anywhere in the body."  

About IntelliCell BioSciences
IntelliCell is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using adult autologous vascular cells (SVC's) derived from the blood vessels in the adult adipose tissue. IntelliCell Biosciences has developed its own patent pending protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. IntelliCell will also be seeking to develop technology-licensing agreements with technology developers, universities, and international business entities.

About Arnold I. Caplan Ph. D.
Dr. Caplan is a Professor of Biology & General Medical Sciences and Director of the Skeletal Research Center at Case Western Reserve University in Cleveland, Ohio.  Professor Caplan has published over 300 manuscripts and articles in peer reviewed journals.  Dr. Caplan ha
'/>"/>

SOURCE IntelliCell BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
2. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
3. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
4. ERT Announces Clearance from German Federal Cartel Office
5. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
6. American Oriental Bioengineering Inc. Announces Suspension of Trading in its Common Stock and the Initiation of Delisting Proceedings by NYSE
7. SIRO Clinpharm Announces a Fabulous Date With the Dueling Pianos
8. Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
9. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
10. The Galien Foundation Announces New "Best Medical Technology" Award Category for 2012 Prix Galien USA Awards Program
11. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014  Dompe, a leader in ... diseases, announces that rhNGF (Recombinant Human Nerve Growth Factor) has ... and Drug Administration (FDA). The candidate drug, ... an orphan drug for the treatment of neurotrophic keratitis, a ... people 1 and is currently without a cure. This ...
(Date:7/23/2014)... CALABASAS, Calif. , July 23, 2014 /PRNewswire/ ... developing revolutionary therapies to treat severe neurological disorders, ... worldwide licensing and collaboration agreement with Shire plc ... (ERT) for potential treatment of both the central ... Hunter syndrome. Also known as MPS II, Hunter ...
(Date:7/23/2014)... MUMBAI , Indien, July 23, 2014 ... bekannt, additional scope für Arbeiten für Sadara ... ein comprehensive Engineering Information System innerhalb des ... implementieren. Dieser award of additional scope im ... Änderung des zuvor abgeschlossenen Vertrags dar, dessen ...
Breaking Medicine Technology:Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 4
(Date:7/23/2014)... On July 21, 2014, My Positive Perspective host ... for an episode that spoke about the group Darkness to ... to talk some about the formation of the group, Tracey ... was started right here in Charleston, originally it was called ... survivors of sexual abuse. Their purpose has shifted to educating ...
(Date:7/23/2014)... As the push for marriage ... understanding the unique circumstances and special needs of ... To help lesbians pursue parenthood with knowledge and ... hosting a free, educational event about pregnancy and ... lesbian couples, not knowing legal and medical options ...
(Date:7/23/2014)... ANTONIO (July 22, 2014) Mouse models of human ... dramatic tumor shrinkage without damage to surrounding tissues, researchers ... at The University of Texas Health Science Center at ... intellectual property on results of the study, which is ... Late diagnosis, low survival , Oral squamous ...
(Date:7/23/2014)... Follow us on LinkedIn ... proportions in both developed and developing countries alike. Rising ... growing preference for processed food, and sedentary lifestyles present ... regarded a disease by itself, obesity is known to ... diabetes, hypertension, cardiovascular risks as well as cancer. The ...
(Date:7/23/2014)... 23, 2014 The Case Management Society of ... Day on the Hill, a one-day event that will bring ... awareness to Congress on the importance of case management to ... on September 10, 2014, at the U.S. Capitol Visitors Center ... Hill provides participants with the opportunity to play a direct ...
Breaking Medicine News(10 mins):Health News:My Positive Perspective Airs Episode to Raise Attention to the Group Darkness to Light 2Health News:Gay Women’s Gathering ™ in Chicago: An Evening about Lesbian Pregnancy 2Health News:Gay Women’s Gathering ™ in Chicago: An Evening about Lesbian Pregnancy 3Health News:Gay Women’s Gathering ™ in Chicago: An Evening about Lesbian Pregnancy 4Health News:Anti-pain agent shrinks oral cancers, leaves healthy tissues alone 2Health News:Surging Obesity Rates Drives Demand for Bariatric (Obesity) Surgical Devices, According to New Report by Global Industry Analysts, Inc. 2Health News:Surging Obesity Rates Drives Demand for Bariatric (Obesity) Surgical Devices, According to New Report by Global Industry Analysts, Inc. 3Health News:Surging Obesity Rates Drives Demand for Bariatric (Obesity) Surgical Devices, According to New Report by Global Industry Analysts, Inc. 4Health News:CMSA Launches Registration for the 2014 Day on the Hill 2
... the cannabis, or marijuana, plant may relax the colon ... study presented at// the 71st Annual Scientific Meeting of ... effects of dronabinol and placebo on colonic motility and ... Mayo Clinic in Rochester, Minnesota conducted a double-blind, parallel-group ...
... chronic heartburn and acid reflux disease (GERD) was linked to ... 71st// Annual Scientific Meeting of the American College of Gastroenterology. ... examined 23 adult patients with GERD (mean age 54 years) ... in May 2006 to ascertain the relationship between halitosis and ...
... Organization has reported that for every four adults in ... 30% of them clinically obese.// ,Obesity which ... day cripple economies. WHO says that although it is ... constitutes a global epidemic. ,Statistics show that ...
... often live in fear after the age of 50 ... study.// ,Jan Lovie-Kitchin and colleagues at the ... where they studied 2,620 adults over 50 years of ... person's life contributed to active ageing. ,The ...
... been repeatedly advised and now reinforced by a study, eating ... good things. Yet another benefit of eating// vegetables like ... risk of developing stomach cancer. ,The study was ... Environmental Medicine of the Karolinska Institute in Sweden. The team ...
... bad news for women faced with the decision about whether ... that screening mammography does reduce breast cancer mortality. The review ... likely to die of breast cancer than women who are ... women in a screened population are 30 percent more likely ...
Cached Medicine News:Health News:Scourge of Obesity 2Health News:Mammograms Reduce Breast Cancer Deaths, But Increase Overdiagnosis 2Health News:Mammograms Reduce Breast Cancer Deaths, But Increase Overdiagnosis 3Health News:Mammograms Reduce Breast Cancer Deaths, But Increase Overdiagnosis 4
Plus cylinders only trial lens set....
This is a reduced form of the 100 Hue test and is obviously quicker to administer. It provides extensive chromatic sensitivity and gives a quantitative score. Kit includes 100 score pads....
... The L'Anthony 15 disc test (P/N ... for copying, and comprehensive instructions. P/N LD15C ... supply of finger tip covers for the ... and accuracy of the color discs). Beware ...
Opti-One multi-purpose solution with citrate protein removal and advanced surfactant combination....
Medicine Products: